| abstract |
The present invention relates to a naphthyramide compound having the structure represented by the general formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof and a hydrate or solvate thereof, and a process for producing the compound, And to its use in the manufacture of a medicament for the prophylaxis and / or treatment of diseases associated with abnormal angiogenesis. ≪ Desc / Clms Page number 2 > |